Find a company
Skin Analytics has already developed an AI melanoma screening tool for use assessing pigmented lesions in primary care and earlier. Two additional technologies could, when coupled with our existing melanoma service, significantly improve the quality of onward referrals into secondary care and enable cost effective population based screening.
These are a non-melanoma skin cancer screening tool, and a change analysis tool. In phase 1 we will develop these tools and aim to show performance levels that indicate that a combined service product can be developed and deployed to significantly improve the skin cancer pathway (phase 2).
| Project | Expansion of Skin Cancer Diagnosis Service |
|---|---|
| Description |
Skin Analytics has already developed an AI melanoma screening tool for use assessing pigmented lesions in primary care and earlier. Two additional technologies could, when coupled with our existing melanoma service, significantly improve the quality of onward referrals into secondary care and enable cost effective population based screening. These are a non-melanoma skin cancer screening tool, and a change analysis tool. In phase 1 we will develop these tools and aim to show performance levels that indicate that a combined service product can be developed and deployed to significantly improve the skin cancer pathway (phase 2). |
| Funding | £ 83,284 |
| Competition | Competition 13 - Cancer: screening, earlier and faster diagnosis |
| Competition Date | September 2017 |
| Categories | Skin , Cancer |
| Health Innovation Network Partner | Imperial College Health Partners |
| Website | https://skin-analytics.com/ |
Skin Analytics has already developed an AI melanoma screening tool for use assessing pigmented lesions in primary care and earlier. Two additional technologies could, when coupled with our existing melanoma service, significantly improve the quality of onward referrals into secondary care and enable cost effective population based screening.
These are a non-melanoma skin cancer screening tool, and a change analysis tool. In phase 1 we will develop these tools and aim to show performance levels that indicate that a combined service product can be developed and deployed to significantly improve the skin cancer pathway (phase 2).
| Project | Streamlining Early Diagnostic Skin Cancer Assessments in the Community using a Class II UKCA-Certified Artificial Intelligence Medical Device |
|---|---|
| Description |
Skin Analytics’ Class II UKCA-Certified Artificial Intelligence Medical Device can support the assessment of skin lesions where there is a suspicion of skin cancer. This technology will be deployed in Community Diagnostic Hubs in pathways co-created with three NHS partners to support faster skin cancer detection and pathway conversion rates. |
| Funding | £ 4,230,091 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer , Skin |
| Health Innovation Network Partner | Imperial College Health Partners |
| Website | https://skin-analytics.com/ |